Follow The Filings

GALTGalectin Therapeutics Inc.

Q3 2023 13F holders among managers we track Latest ownership dossier

Ticker
GALT
Type
Equity
Class
COM NEW
Total reported value (long equity)
Manager Report date Value Shares